Cargando…
Long COVID-19—it's not over until?
Autores principales: | Yelin, Dana, Margalit, Ili, Yahav, Dafna, Runold, Michael, Bruchfeld, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832095/ https://www.ncbi.nlm.nih.gov/pubmed/33316400 http://dx.doi.org/10.1016/j.cmi.2020.12.001 |
Ejemplares similares
-
ESCMID rapid guidelines for assessment and management of long COVID
por: Yelin, Dana, et al.
Publicado: (2022) -
Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nave, Lior, et al.
Publicado: (2023) -
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
por: Yahav, Dafna, et al.
Publicado: (2021) -
Long-term consequences of COVID-19: research needs
por: Yelin, Dana, et al.
Publicado: (2020) -
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study
por: Yelin, Dana, et al.
Publicado: (2022)